Table 2 |
|||||||
|
Transgenic mouse models of breast cancer metastasis |
|||||||
|
TG mouse model |
Expression |
Tumor incidence (%) |
Tumor latency (months) |
Metastasis incidence (%) |
Metastatic site |
Metastasis latency (months) |
References |
|
|
|||||||
|
Single-transgenic mice |
|||||||
|
MMTV-Cox2 |
Mammary gland |
>85 |
7a |
b |
LN |
[101] |
|
|
MMTV-Wnt1 |
Mammary gland |
60 |
8 |
b |
Lung, LN |
[7,16,77] |
|
|
MMTV-Neu |
Mammary gland |
100 |
6.8a |
72 |
Lung |
8 |
[16,102] |
|
MMTV-Neu activated |
Mammary gland |
100 |
3a-5 |
20 |
Lung |
3.5 |
[42,44] |
|
MMTV-Neu (YB) |
Mammary gland |
100 |
6a |
65 |
Lung |
2 |
[44,67] |
|
MMTV-Neu (YD) |
Mammary gland |
100 |
3.6a |
44 |
Lung |
2 |
|
|
MMTV-PyMT |
Mammary gland |
100 |
1–6 |
>85; 51 |
Lung; LN |
3.5 |
[16,45,51] |
|
MTB-TAN |
Mammary gland |
100 |
- |
92 |
Lung |
[16,103] |
|
|
MT-Met |
Mammary gland |
b |
10 |
b |
Lung; LN; kidney; heart; cecum |
[16,104] |
|
|
C3(1)-Tag |
Mammary gland |
100 |
3–6 |
b |
Lung |
[16,105] |
|
|
Wap-Notch4 |
Mammary gland |
100 |
6.2 |
High |
Lung |
[106] |
|
|
Wap-T-NP |
Mammary gland |
12–83 |
11 |
b |
Lung, LN |
[107] |
|
|
Wap-Ras |
Mammary gland, salivary gland |
100 |
6 |
14 |
Lung |
[16,108] |
|
|
Wap-HGF |
Mammary gland |
89 |
1–2 |
22 |
Lung |
1–2 |
[109] |
|
H19-IGF2 |
Mammary gland |
50–100 |
>9 |
38 |
Lung, spleen; liver |
[16,110] |
|
|
Composite-transgenic mice |
|||||||
|
p53fp/fp MMTV-Cre Wap-Cre |
Mammary gland deletion |
100 |
10–18a |
50 |
Lung, liver |
[111] |
|
|
p53+/- MMTV-ΔN-β-catenin |
Mammary gland |
100 |
9.8a |
39 |
Lung |
[112] |
|
|
CD44-/-MMTV-PyMT |
Mammary gland |
100 |
3.5a |
66 |
Lung |
3.5 |
[12] |
|
MMTV-Neu;SR2F |
Mammary gland |
86.8 |
8a |
12 |
Lung |
[70] |
|
|
MMTV-NeuYB;TβRI(AAD) |
Mammary gland |
8.9a |
65 |
Lung |
2 |
[67] |
|
|
MMTV-NeuYD;TβRI(AAD) |
Mammary gland |
4.4a |
44 |
>Extravascular |
|||
|
MMTV-NeuYB;TβRII(ΔCyt) |
Mammary gland |
6a |
65 |
<Extravascular |
|||
|
MMTV-rtTA/TetOp-TGF-β1S223/225; MMTV-PyMT |
Mammary gland |
1.8a |
>10-fold |
Lung |
3.2 |
[68] |
|
|
MMTV-Neu; S100A4 |
Mammary gland |
12 |
50 |
Lung |
[16,113] |
||
|
MMTV-Wnt1; int2 |
Mammary gland |
90 |
4a |
b |
Lung, LN |
[7,77] |
|
|
MMTV-PyMT; uPA-/- |
Mammary gland |
100 |
1.5a |
31 |
Lung, LN |
3.5 |
[45,51,52] |
|
MMTV-PyMT; Plg-/- |
Mammary gland |
100 |
1.5a |
25c |
Lung |
3 |
|
|
MMTV-PyMT; VEGF |
Mammary gland |
100 |
1–2 |
100 |
Lung |
2 |
[91] |
|
MMTV-PyMT; MEKK1-/- |
Mammary gland |
100 |
3 |
25 |
Lung |
4 |
[53] |
|
|
|||||||
|
aTumor t50 was reported; bmetastasis/tumor appearance but not incidence was reported; clung metastasis in all Plg-/- mice analyzed versus 56% in control mice; metastasis was dependent on tumor burden. HGF, hepatocyte growth factor; LN, lymph nodes. |
|||||||
|
Fantozzi and Christofori Breast Cancer Research 2006 8:212 doi:10.1186/bcr1530 |
|||||||